ID   OGT1_RAT                Reviewed;        1036 AA.
AC   P56558;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-1998, sequence version 1.
DT   02-OCT-2024, entry version 176.
DE   RecName: Full=UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit;
DE            EC=2.4.1.255 {ECO:0000269|PubMed:10542233, ECO:0000269|PubMed:24995978};
DE   AltName: Full=O-GlcNAc transferase subunit p110;
DE   AltName: Full=O-linked N-acetylglucosamine transferase 110 kDa subunit;
DE            Short=OGT;
GN   Name=Ogt;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, TISSUE SPECIFICITY,
RP   PHOSPHORYLATION AT TYR-979, GLYCOSYLATION, SUBCELLULAR LOCATION, AND
RP   PROBABLE PROCESSING.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=9083067; DOI=10.1074/jbc.272.14.9308;
RA   Kreppel L.K., Blomberg M.A., Hart G.W.;
RT   "Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and
RT   characterization of a unique O-GlcNAc transferase with multiple
RT   tetratricopeptide repeats.";
RL   J. Biol. Chem. 272:9308-9315(1997).
RN   [2]
RP   FUNCTION, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Liver;
RX   PubMed=1533623; DOI=10.1016/s0021-9258(19)50380-5;
RA   Haltiwanger R.S., Blomberg M.A., Hart G.W.;
RT   "Glycosylation of nuclear and cytoplasmic proteins. Purification and
RT   characterization of a uridine diphospho-N-acetylglucosamine:polypeptide
RT   beta-N-acetylglucosaminyltransferase.";
RL   J. Biol. Chem. 267:9005-9013(1992).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=10580430; DOI=10.2337/diabetes.48.12.2407;
RA   Akimoto Y., Kreppel L.K., Hirano H., Hart G.W.;
RT   "Localization of the O-linked N-acetylglucosamine transferase in rat
RT   pancreas.";
RL   Diabetes 48:2407-2413(1999).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND MUTAGENESIS OF 2-MET--ARG-274
RP   AND 2-MET--ALA-173.
RX   PubMed=10542233; DOI=10.1074/jbc.274.45.32015;
RA   Kreppel L.K., Hart G.W.;
RT   "Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the
RT   tetratricopeptide repeats.";
RL   J. Biol. Chem. 274:32015-32022(1999).
RN   [5]
RP   SUBCELLULAR LOCATION, INTERACTION WITH ATXN10, SUBUNIT, TISSUE SPECIFICITY,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16714295; DOI=10.1074/jbc.m601563200;
RA   Maerz P., Stetefeld J., Bendfeldt K., Nitsch C., Reinstein J.,
RA   Shoeman R.L., Dimitriades-Schmutz B., Schwager M., Leiser D., Ozcan S.,
RA   Otten U., Ozbek S.;
RT   "Ataxin-10 interacts with O-linked beta-N-acetylglucosamine transferase in
RT   the brain.";
RL   J. Biol. Chem. 281:20263-20270(2006).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHATIDYLINOSITOL-BINDING, AND
RP   MUTAGENESIS OF 981-LYS-LYS-982; ARG-984; LYS-986; LYS-989; ARG-991 AND
RP   LYS-1000.
RX   PubMed=18288188; DOI=10.1038/nature06668;
RA   Yang X., Ongusaha P.P., Miles P.D., Havstad J.C., Zhang F., So W.V.,
RA   Kudlow J.E., Michell R.H., Olefsky J.M., Field S.J., Evans R.M.;
RT   "Phosphoinositide signalling links O-GlcNAc transferase to insulin
RT   resistance.";
RL   Nature 451:964-969(2008).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, PATHWAY, INTERACTION WITH KIF5B;
RP   RHOT1; RHOT2 AND TRAK1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   2-MET--MET-129; 2-MET--HIS-248 AND HIS-498.
RX   PubMed=24995978; DOI=10.1016/j.cell.2014.06.007;
RA   Pekkurnaz G., Trinidad J.C., Wang X., Kong D., Schwarz T.L.;
RT   "Glucose regulates mitochondrial motility via Milton modification by O-
RT   GlcNAc transferase.";
RL   Cell 158:54-68(2014).
CC   -!- FUNCTION: Catalyzes the transfer of a single N-acetylglucosamine from
CC       UDP-GlcNAc to a serine or threonine residue in cytoplasmic and nuclear
CC       proteins resulting in their modification with a beta-linked N-
CC       acetylglucosamine (O-GlcNAc) (PubMed:10542233, PubMed:24995978).
CC       Glycosylates a large and diverse number of proteins including histone
CC       H2B, AKT1, AMPK, ATG4B, CAPRIN1, EZH2, FNIP1, GSDMD, KRT7, LMNA, LMNB1,
CC       LMNB2, RPTOR, HOXA1, PFKL, KMT2E/MLL5, MAPT/TAU, TET2, RBL2, RET, NOD2
CC       and HCFC1 (PubMed:10542233). Can regulate their cellular processes via
CC       cross-talk between glycosylation and phosphorylation or by affecting
CC       proteolytic processing (By similarity). Involved in insulin resistance
CC       in muscle and adipocyte cells via glycosylating insulin signaling
CC       components and inhibiting the 'Thr-308' phosphorylation of AKT1,
CC       enhancing IRS1 phosphorylation and attenuating insulin signaling
CC       (PubMed:18288188). Involved in glycolysis regulation by mediating
CC       glycosylation of 6-phosphofructokinase PFKL, inhibiting its activity
CC       (By similarity). Plays a key role in chromatin structure by mediating
CC       O-GlcNAcylation of 'Ser-112' of histone H2B: recruited to CpG-rich
CC       transcription start sites of active genes via its interaction with TET
CC       proteins (TET1, TET2 or TET3) (By similarity). As part of the NSL
CC       complex indirectly involved in acetylation of nucleosomal histone H4 on
CC       several lysine residues (By similarity). O-GlcNAcylation of 'Ser-75' of
CC       EZH2 increases its stability, and facilitating the formation of
CC       H3K27me3 by the PRC2/EED-EZH2 complex (By similarity). Stabilizes
CC       KMT2E/MLL5 by mediating its glycosylation, thereby preventing
CC       KMT2E/MLL5 ubiquitination (By similarity). Regulates circadian
CC       oscillation of the clock genes and glucose homeostasis in the liver (By
CC       similarity). Stabilizes clock proteins BMAL1 and CLOCK through O-
CC       glycosylation, which prevents their ubiquitination and subsequent
CC       degradation (By similarity). Promotes the CLOCK-BMAL1-mediated
CC       transcription of genes in the negative loop of the circadian clock such
CC       as PER1/2 and CRY1/2 (By similarity). O-glycosylates HCFC1 and
CC       regulates its proteolytic processing and transcriptional activity (By
CC       similarity). Component of a THAP1/THAP3-HCFC1-OGT complex that is
CC       required for the regulation of the transcriptional activity of RRM1 (By
CC       similarity). Regulates mitochondrial motility in neurons by mediating
CC       glycosylation of TRAK1 (PubMed:24995978). Promotes autophagy by
CC       mediating O-glycosylation of ATG4B (By similarity). Acts as a regulator
CC       of mTORC1 signaling by mediating O-glycosylation of RPTOR and FNIP1: O-
CC       GlcNAcylation of RPTOR in response to glucose sufficiency promotes
CC       activation of the mTORC1 complex (By similarity).
CC       {ECO:0000250|UniProtKB:O15294, ECO:0000250|UniProtKB:Q8CGY8,
CC       ECO:0000269|PubMed:10542233, ECO:0000269|PubMed:1533623,
CC       ECO:0000269|PubMed:18288188, ECO:0000269|PubMed:24995978}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-glucosamine = 3-O-(N-
CC         acetyl-beta-D-glucosaminyl)-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:48904, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12251,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:57705,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:90838; EC=2.4.1.255;
CC         Evidence={ECO:0000269|PubMed:10542233, ECO:0000269|PubMed:24995978};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-glucosamine = 3-O-
CC         (N-acetyl-beta-D-glucosaminyl)-L-threonyl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:48908, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:12252,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:57705,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:90840; EC=2.4.1.255;
CC         Evidence={ECO:0000269|PubMed:10542233, ECO:0000269|PubMed:24995978};
CC   -!- ACTIVITY REGULATION: Inhibited by UDP, UTP and UDP-GlcNAc; 50 mM NaCl
CC       or KCl inhibit activity about 70%. {ECO:0000269|PubMed:1533623}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.0. {ECO:0000269|PubMed:1533623};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:24995978}.
CC   -!- SUBUNIT: Monomer; may exist in different oligomerization states in
CC       cells (By similarity). Homotrimer, oligomerizes via TPR repeats 6 and 7
CC       (By similarity). Trimerization is not necessary for activity in vitro,
CC       however it increases affinity for UDP-GlcNAc (PubMed:10542233). A
CC       heterotrimer consisting of two 110 kDa subunits and one highly related
CC       78 kDa subunit is isolated from liver (PubMed:1533623). Component of a
CC       THAP1/THAP3-HCFC1-OGT complex (By similarity). Component of the NSL
CC       complex at least composed of MOF/KAT8, KANSL1, KANSL2, KANSL3, MCRS1,
CC       PHF20, OGT1/OGT, WDR5 and HCFC1 (By similarity). Found in a complex
CC       with KIF5B, RHOT1, RHOT2 and TRAK1 (PubMed:24995978). Found in a
CC       complex composed of at least SINHCAF, SIN3A, HDAC1, SAP30, RBBP4, OGT
CC       and TET1 (By similarity). Component of a complex composed of
CC       KMT2E/MLL5, OGT and USP7; the complex stabilizes KMT2E/MLL5, preventing
CC       KMT2E/MLL5 ubiquitination and proteasomal-mediated degradation (By
CC       similarity). Interacts (via TPRs 1-6) with SIN3A; the interaction
CC       mediates transcriptional repression in parallel with histone
CC       deacetylase (By similarity). Interacts (via TPR 5-6) with TET1, TET2
CC       and TET3 (By similarity). Interacts (via TPR repeats 6 and 7) with
CC       ATXN10 (PubMed:16714295). Interacts with NSD2 (By similarity).
CC       Interacts with PROSER1; this interaction mediates TET2 O-GlcNAcylation
CC       and stability by promoting the interaction between OGT and TET2 (By
CC       similarity). {ECO:0000250|UniProtKB:O15294,
CC       ECO:0000250|UniProtKB:Q8CGY8, ECO:0000269|PubMed:10542233,
CC       ECO:0000269|PubMed:1533623, ECO:0000269|PubMed:16714295,
CC       ECO:0000269|PubMed:24995978}.
CC   -!- INTERACTION:
CC       P56558; Q9WVH3: Foxo4; Xeno; NbExp=2; IntAct=EBI-7614183, EBI-4567305;
CC       P56558; Q9WU00: Nrf1; Xeno; NbExp=2; IntAct=EBI-7614183, EBI-11291138;
CC       P56558; Q9UPV9: TRAK1; Xeno; NbExp=6; IntAct=EBI-7614183, EBI-1105048;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1533623,
CC       ECO:0000269|PubMed:16714295, ECO:0000269|PubMed:24995978,
CC       ECO:0000269|PubMed:9083067}. Nucleus {ECO:0000269|PubMed:18288188,
CC       ECO:0000269|PubMed:24995978, ECO:0000269|PubMed:9083067}. Cell membrane
CC       {ECO:0000269|PubMed:18288188}. Mitochondrion membrane
CC       {ECO:0000269|PubMed:24995978}. Cell projection
CC       {ECO:0000269|PubMed:24995978}. Note=Mostly in the nucleus
CC       (PubMed:9083067). After insulin induction, translocated from the
CC       nucleus to the cell membrane via phosphatidylinositide binding.
CC       Colocalizes with AKT1 at the plasma membrane (PubMed:18288188). TRAK1
CC       recruits this protein to mitochondria (PubMed:24995978). In the absence
CC       of TRAK1, localizes in cytosol and nucleus (PubMed:24995978).
CC       Translocates into the nucleus via association with importin KPNA1 (By
CC       similarity). {ECO:0000250|UniProtKB:O15294,
CC       ECO:0000269|PubMed:18288188, ECO:0000269|PubMed:24995978,
CC       ECO:0000305|PubMed:9083067}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain, heart, liver, thymus, muscle,
CC       lung, spleen, uterus and ovary; in the kidney only an immunologically-
CC       related 78 kDa band is present, which is also present in liver and
CC       muscle (PubMed:9083067). In the pancreas, expressed in both exocrine
CC       acinar cells and in endocrine cells of the islets of Langerhans.
CC       {ECO:0000269|PubMed:10580430, ECO:0000269|PubMed:16714295,
CC       ECO:0000269|PubMed:9083067}.
CC   -!- DOMAIN: The TPR repeat domain is required for substrate binding and
CC       oligomerization. {ECO:0000250|UniProtKB:O15294,
CC       ECO:0000269|PubMed:24995978}.
CC   -!- PTM: Several different immunologically-related forms of this protein
CC       are found in different tissues (with apparent molecular weights of 110,
CC       80 and 78 kDa); they are probably the result of alternative splicing
CC       and/or proteolysis. {ECO:0000269|PubMed:9083067}.
CC   -!- PTM: O-glycosylated; contains O-GlcNAc. Both p110 and p78 forms are O-
CC       glycosylated. {ECO:0000269|PubMed:9083067}.
CC   -!- PTM: Ubiquitinated, leading to its proteasomal degradation.
CC       {ECO:0000250|UniProtKB:O15294}.
CC   -!- PTM: Phosphorylation on Ser-3 or Ser-4 by GSK3-beta positively
CC       regulates its activity (By similarity). Phosphorylation at Thr-444 by
CC       AMPK promotes nuclear localization (By similarity).
CC       {ECO:0000250|UniProtKB:O15294, ECO:0000250|UniProtKB:Q8CGY8}.
CC   -!- PTM: Glycosylated via autocatalysis; O-GlcNAcylation at Ser-389
CC       promotes nuclear localization. {ECO:0000250|UniProtKB:O15294}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 41 family. O-GlcNAc
CC       transferase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U76557; AAC53121.1; -; mRNA.
DR   PIR; T31673; T31673.
DR   RefSeq; NP_058803.2; NM_017107.2.
DR   AlphaFoldDB; P56558; -.
DR   SMR; P56558; -.
DR   BioGRID; 247798; 6.
DR   IntAct; P56558; 5.
DR   MINT; P56558; -.
DR   STRING; 10116.ENSRNOP00000072791; -.
DR   CAZy; GT41; Glycosyltransferase Family 41.
DR   GlyCosmos; P56558; 2 sites, No reported glycans.
DR   GlyGen; P56558; 3 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P56558; -.
DR   PhosphoSitePlus; P56558; -.
DR   jPOST; P56558; -.
DR   PaxDb; 10116-ENSRNOP00000004692; -.
DR   GeneID; 26295; -.
DR   KEGG; rno:26295; -.
DR   UCSC; RGD:62060; rat.
DR   AGR; RGD:62060; -.
DR   CTD; 8473; -.
DR   RGD; 62060; Ogt.
DR   eggNOG; KOG1124; Eukaryota.
DR   eggNOG; KOG4626; Eukaryota.
DR   InParanoid; P56558; -.
DR   OrthoDB; 34780at2759; -.
DR   PhylomeDB; P56558; -.
DR   BRENDA; 2.4.1.255; 5301.
DR   Reactome; R-RNO-3214847; HATs acetylate histones.
DR   Reactome; R-RNO-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-RNO-5689603; UCH proteinases.
DR   Reactome; R-RNO-9772755; Formation of WDR5-containing histone-modifying complexes.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:P56558; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-SubCell.
DR   GO; GO:0150048; C:cerebellar granule cell to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0000791; C:euchromatin; IDA:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0000123; C:histone acetyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0044545; C:NSL complex; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR   GO; GO:0017122; C:protein N-acetylglucosaminyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0042588; C:zymogen granule; IDA:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0042277; F:peptide binding; IDA:RGD.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0097363; F:protein O-acetylglucosaminyltransferase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISS:UniProtKB.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IMP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IMP:RGD.
DR   GO; GO:0097237; P:cellular response to toxic substance; IEP:RGD.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; IEP:RGD.
DR   GO; GO:0006041; P:glucosamine metabolic process; IDA:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0048312; P:intracellular distribution of mitochondria; IMP:RGD.
DR   GO; GO:0000423; P:mitophagy; ISO:RGD.
DR   GO; GO:1900038; P:negative regulation of cellular response to hypoxia; IMP:RGD.
DR   GO; GO:0160076; P:negative regulation of non-canonical inflammasome complex assembly; ISS:UniProtKB.
DR   GO; GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; IMP:RGD.
DR   GO; GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; IMP:RGD.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0090315; P:negative regulation of protein targeting to membrane; IMP:RGD.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0045793; P:positive regulation of cell size; IMP:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0046889; P:positive regulation of lipid biosynthetic process; ISO:RGD.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IMP:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0045862; P:positive regulation of proteolysis; ISS:UniProtKB.
DR   GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; IMP:RGD.
DR   GO; GO:1904263; P:positive regulation of TORC1 signaling; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0000432; P:positive regulation of transcription from RNA polymerase II promoter by glucose; ISO:RGD.
DR   GO; GO:0045727; P:positive regulation of translation; ISO:RGD.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IDA:RGD.
DR   GO; GO:0016485; P:protein processing; ISS:UniProtKB.
DR   GO; GO:0006111; P:regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0006110; P:regulation of glycolytic process; ISS:UniProtKB.
DR   GO; GO:0046626; P:regulation of insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0098696; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0035020; P:regulation of Rac protein signal transduction; ISO:RGD.
DR   GO; GO:0051963; P:regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032868; P:response to insulin; ISO:RGD.
DR   Gene3D; 3.30.720.150; -; 1.
DR   Gene3D; 3.40.50.11380; -; 1.
DR   Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 1.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 2.
DR   InterPro; IPR029489; OGT/SEC/SPY_C.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR44366; UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N-ACETYLGLUCOSAMINYLTRANSFERASE 110 KDA SUBUNIT; 1.
DR   PANTHER; PTHR44366:SF1; UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N-ACETYLGLUCOSAMINYLTRANSFERASE 110 KDA SUBUNIT; 1.
DR   Pfam; PF13844; Glyco_transf_41; 1.
DR   Pfam; PF00515; TPR_1; 2.
DR   Pfam; PF13414; TPR_11; 3.
DR   Pfam; PF13424; TPR_12; 1.
DR   Pfam; PF13181; TPR_8; 2.
DR   SMART; SM00028; TPR; 12.
DR   SUPFAM; SSF48452; TPR-like; 3.
DR   PROSITE; PS50005; TPR; 12.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Biological rhythms; Cell membrane; Cell projection;
KW   Chromatin regulator; Cytoplasm; Direct protein sequencing; Glycoprotein;
KW   Glycosyltransferase; Lipid-binding; Membrane; Mitochondrion; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; TPR repeat; Transferase;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   CHAIN           2..1036
FT                   /note="UDP-N-acetylglucosamine--peptide N-
FT                   acetylglucosaminyltransferase 110 kDa subunit"
FT                   /id="PRO_0000191774"
FT   REPEAT          11..44
FT                   /note="TPR 1"
FT   REPEAT          79..112
FT                   /note="TPR 2"
FT   REPEAT          113..146
FT                   /note="TPR 3"
FT   REPEAT          147..180
FT                   /note="TPR 4"
FT   REPEAT          181..214
FT                   /note="TPR 5"
FT   REPEAT          215..248
FT                   /note="TPR 6"
FT   REPEAT          249..282
FT                   /note="TPR 7"
FT   REPEAT          283..316
FT                   /note="TPR 8"
FT   REPEAT          317..350
FT                   /note="TPR 9"
FT   REPEAT          351..384
FT                   /note="TPR 10"
FT   REPEAT          385..418
FT                   /note="TPR 11"
FT   REPEAT          419..452
FT                   /note="TPR 12"
FT   REPEAT          453..463
FT                   /note="TPR 13; truncated"
FT   REGION          981..1000
FT                   /note="Required for phosphatidylinositol 3,4,5-triphosphate
FT                   binding"
FT                   /evidence="ECO:0000269|PubMed:18288188"
FT   MOTIF           454..456
FT                   /note="DFP motif"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   MOTIF           478..493
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        498
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000269|PubMed:24995978"
FT   BINDING         839
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   BINDING         842
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   BINDING         896..898
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   BINDING         901..904
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   BINDING         920..922
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   BINDING         925
FT                   /ligand="UDP"
FT                   /ligand_id="ChEBI:CHEBI:58223"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   MOD_RES         3
FT                   /note="Phosphoserine; by GSK3-beta; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGY8"
FT   MOD_RES         4
FT                   /note="Phosphoserine; by GSK3-beta; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGY8"
FT   MOD_RES         444
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   MOD_RES         979
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000305|PubMed:9083067"
FT   CARBOHYD        3
FT                   /note="O-linked (GlcNAc) serine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGY8"
FT   CARBOHYD        4
FT                   /note="O-linked (GlcNAc) serine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGY8"
FT   CARBOHYD        389
FT                   /note="O-linked (GlcNAc) serine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O15294"
FT   MUTAGEN         2..274
FT                   /note="Missing: Wild-type O-GlcNAc transferase activity,
FT                   does not form trimers."
FT                   /evidence="ECO:0000269|PubMed:10542233"
FT   MUTAGEN         2..248
FT                   /note="Missing: Decreased TRAK1 O-glycosylation by this
FT                   protein."
FT                   /evidence="ECO:0000269|PubMed:24995978"
FT   MUTAGEN         2..173
FT                   /note="Missing: Wild-type O-GlcNAc transferase activity,
FT                   forms trimers."
FT                   /evidence="ECO:0000269|PubMed:10542233"
FT   MUTAGEN         2..129
FT                   /note="Missing: Decreased ability to reduce neuronal
FT                   mitochondrial motility in both anterograde and retrograde
FT                   directions."
FT                   /evidence="ECO:0000269|PubMed:24995978"
FT   MUTAGEN         498
FT                   /note="H->N: Loss of glycosylation activity. Loss of
FT                   ability to reduce mitochondrial motility."
FT                   /evidence="ECO:0000269|PubMed:24995978"
FT   MUTAGEN         981..982
FT                   /note="KK->AA: Abolishes phosphatidylinisitol binding, no
FT                   translocation to the cell membrane, and no effect on
FT                   phosphorylation of AKT1 nor IRS1."
FT                   /evidence="ECO:0000269|PubMed:18288188"
FT   MUTAGEN         984
FT                   /note="R->A: No effect on phosphatidylinisitol binding."
FT                   /evidence="ECO:0000269|PubMed:18288188"
FT   MUTAGEN         986
FT                   /note="K->A: Reduced phosphatidylinisitol binding."
FT                   /evidence="ECO:0000269|PubMed:18288188"
FT   MUTAGEN         989
FT                   /note="K->A: Reduced phosphatidylinisitol binding."
FT                   /evidence="ECO:0000269|PubMed:18288188"
FT   MUTAGEN         991
FT                   /note="R->A: No effect on phosphatidylinisitol binding."
FT                   /evidence="ECO:0000269|PubMed:18288188"
FT   MUTAGEN         1000
FT                   /note="K->A: No effect on phosphatidylinisitol binding."
FT                   /evidence="ECO:0000269|PubMed:18288188"
SQ   SEQUENCE   1036 AA;  115606 MW;  3F057CABDD019BD6 CRC64;
     MASSVGNVAD STGLAELAHR EYQAGDFEAA ERHCMQLWRQ EPDNTGVLLL LSSIHFQCRR
     LDRSAHFSTL AIKQNPLLAE AYSNLGNVYK ERGQLQEAIE HYRHALRLKP DFIDGYINLA
     AALVAAGDME GAVQAYVSAL QYNPDLYCVR SDLGNLLKAL GRLEEAKACY LKAIETQPNF
     AVAWSNLGCV FNAQGEIWLA IHHFEKAVTL DPNFLDAYIN LGNVLKEARI FDRAVAAYLR
     ALSLSPNHAV VHGNLACVYY EQGLIDLAID TYRRAIELQP HFPDAYCNLA NALKEKGSVA
     EAEDCYNTAL RLCPTHADSL NNLANIKREQ GNIEEAVRLY RKALEVFPEF AAAHSNLASV
     LQQQGKLQEA LMHYKEAIRI SPTFADAYSN MGNTLKEMQD VQGALQCYTR AIQINPAFAD
     AHSNLASIHK DSGNIPEAIA SYRTALKLKP DFPDAYCNLA HCLQIVCDWT DYDERMKKLV
     SIVAEQLEKN RLPSVHPHHS MLYPLSHGFR KAIAERHGNL CLDKINVLHK PPYEHPKDLK
     LSDGRLRVGY VSSDFGNHPT SHLMQSIPGM HNPDKFEVFC YALSPDDGTN FRVKVMAEAN
     HFIDLSQIPC NGKAADRIHQ DGIHILVNMN GYTKGARNEL FALRPAPIQA MWLGYPGTSG
     ALFMDYIITD QETSPAEVAE QYSEKLAYMP HTFFIGDHAN MFPHLKKKAV IDFKSNGHIY
     DNRIVLNGID LKAFLDSLPD VKIVKMKCPD GGDNADTTNT ALNMPVIPMN TIAEAVIEMI
     NRGQIQITIN GFSISNGLAT TQINNKAATG EEVPRTIIVT TRSQYGLPED AIVYCNFNQL
     YKIDPSTLQM GANILKRVPN SVLWLLRFPA VGEPNIQQYA QNMGLPQNRI IFSPVAPKEE
     HVRRGQLADV CLDTPLCNGH TTGMDVLWAG TPMVTMPGET LASRVAASQL TCLGCLELIA
     KSRQEYEDIA VKLGTDLEYL KKIRGKVWKQ RISSPLFNTK QYTMELERLY LQMWEHYAAG
     NKPDHMIKPV EVTESA
//
